血管緊張素Ⅱ受體1(AGTR1)重組蛋白
Recombinant Angiotensin II Receptor 1 (AGTR1)
AT1R; AG2S; AG2-S; AGTR1A; AGTR1B; AT1; AT1B; AT2R1; AT2-R1; AT2R1A; AT2R1B; HAT1R; AT1 Receptor; Angiotensin Receptor 1B
- 編號RPB658Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞膜
- 預測分子量17.7kDa
- 實際分子量25kDa(差異分析請參閱說明書)
- 片段與標簽Met1~Ile124 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點8.3
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1195 ¥ 2988 ¥ 5976 ¥ 17928 ¥ 44820
- 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
序列
![](http://static.cloud-clone.cn/product/pictures/RPB658Hu01-202108050902137271.jpg)
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
增值服務
相關產品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPB658Hu02 | 血管緊張素Ⅱ受體1(AGTR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB658Hu03 | 血管緊張素Ⅱ受體1(AGTR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB658Hu01 | 血管緊張素Ⅱ受體1(AGTR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB658Hu01 | 血管緊張素Ⅱ受體1(AGTR1)多克隆抗體 | WB; IHC; ICC; IP. |
MAB658Hu22 | 血管緊張素Ⅱ受體1(AGTR1)單克隆抗體 | WB; IHC; ICC; IP. |
SEB658Hu | 血管緊張素Ⅱ受體1(AGTR1)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB658Hu | 血管緊張素Ⅱ受體1(AGTR1)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Journal of Atherosclerosis and Thrombosis | Involvement of Angiotensin II Type 1 and 2 Receptors in Gelatinase ReCavia (Guinea pig )lation in Human Carotid Atheroma in vitro [Pubmed:26947595] |
European Journal of Pharmaceutical Sciences | Vitamin D3 potentiates the renoprotective effects of vildagliptin in a rat model of fructose/salt-induced insulin resistance [Pubmed: 31866564] |
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | Vitamin D3 potentiates the nephroprotective effects of metformin in a rat model of metabolic syndrome: Role of AMPK/SIRT1 activation and DPP-4 inhibition [Pubmed: 33108744] |
Fundam Clin Pharmacol | Vitamin D3 potentiates the nephroprotective effects of vildagliptin‐metformin combination in a rat model of metabolic syndrome [34453360] |
留言咨詢